STRATEC SE (SBS.DE) Stock Fundamental Analysis

FRA:SBS • DE000STRA555

19.98 EUR
-0.42 (-2.06%)
Last: Feb 23, 2026, 11:57 AM
Fundamental Rating

5

Overall SBS gets a fundamental rating of 5 out of 10. We evaluated SBS against 65 industry peers in the Health Care Equipment & Supplies industry. SBS has only an average score on both its financial health and profitability. SBS has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • SBS had positive earnings in the past year.
  • SBS had a positive operating cash flow in the past year.
  • SBS had positive earnings in each of the past 5 years.
  • In the past 5 years SBS always reported a positive cash flow from operatings.
SBS.DE Yearly Net Income VS EBIT VS OCF VS FCFSBS.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

1.2 Ratios

  • SBS has a Return On Assets (3.72%) which is comparable to the rest of the industry.
  • SBS has a Return On Equity of 6.67%. This is comparable to the rest of the industry: SBS outperforms 50.77% of its industry peers.
  • The Return On Invested Capital of SBS (5.32%) is comparable to the rest of the industry.
  • The Average Return On Invested Capital over the past 3 years for SBS is below the industry average of 9.73%.
Industry RankSector Rank
ROA 3.72%
ROE 6.67%
ROIC 5.32%
ROA(3y)4.79%
ROA(5y)6.56%
ROE(3y)8.69%
ROE(5y)12.02%
ROIC(3y)6.93%
ROIC(5y)8.13%
SBS.DE Yearly ROA, ROE, ROICSBS.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

  • SBS has a Profit Margin of 6.22%. This is comparable to the rest of the industry: SBS outperforms 50.77% of its industry peers.
  • SBS's Profit Margin has declined in the last couple of years.
  • SBS has a Operating Margin (10.94%) which is comparable to the rest of the industry.
  • SBS's Operating Margin has improved in the last couple of years.
  • With a Gross Margin value of 29.65%, SBS is not doing good in the industry: 84.62% of the companies in the same industry are doing better.
  • In the last couple of years the Gross Margin of SBS has grown nicely.
Industry RankSector Rank
OM 10.94%
PM (TTM) 6.22%
GM 29.65%
OM growth 3Y-14.59%
OM growth 5Y5.17%
PM growth 3Y-23.53%
PM growth 5Y-1.6%
GM growth 3Y-0.97%
GM growth 5Y4.52%
SBS.DE Yearly Profit, Operating, Gross MarginsSBS.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

5

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), SBS is creating some value.
  • The number of shares outstanding for SBS remains at a similar level compared to 1 year ago.
  • The number of shares outstanding for SBS has been increased compared to 5 years ago.
  • The debt/assets ratio for SBS has been reduced compared to a year ago.
SBS.DE Yearly Shares OutstandingSBS.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
SBS.DE Yearly Total Debt VS Total AssetsSBS.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

  • SBS has an Altman-Z score of 2.66. This is not the best score and indicates that SBS is in the grey zone with still only limited risk for bankruptcy at the moment.
  • SBS has a Altman-Z score (2.66) which is in line with its industry peers.
  • The Debt to FCF ratio of SBS is 41.27, which is on the high side as it means it would take SBS, 41.27 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of SBS (41.27) is worse than 63.08% of its industry peers.
  • SBS has a Debt/Equity ratio of 0.49. This is a healthy value indicating a solid balance between debt and equity.
  • With a Debt to Equity ratio value of 0.49, SBS perfoms like the industry average, outperforming 46.15% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF 41.27
Altman-Z 2.66
ROIC/WACC0.8
WACC6.65%
SBS.DE Yearly LT Debt VS Equity VS FCFSBS.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

  • SBS has a Current Ratio of 4.19. This indicates that SBS is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Current ratio value of 4.19, SBS belongs to the best of the industry, outperforming 93.85% of the companies in the same industry.
  • SBS has a Quick Ratio of 1.65. This is a normal value and indicates that SBS is financially healthy and should not expect problems in meeting its short term obligations.
  • SBS has a better Quick ratio (1.65) than 73.85% of its industry peers.
Industry RankSector Rank
Current Ratio 4.19
Quick Ratio 1.65
SBS.DE Yearly Current Assets VS Current LiabilitesSBS.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

4

3. Growth

3.1 Past

  • The Earnings Per Share has been growing slightly by 4.26% over the past year.
  • SBS shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 2.20% yearly.
  • SBS shows a decrease in Revenue. In the last year, the revenue decreased by -4.73%.
  • Measured over the past years, SBS shows a small growth in Revenue. The Revenue has been growing by 3.76% on average per year.
EPS 1Y (TTM)4.26%
EPS 3Y-26.21%
EPS 5Y2.2%
EPS Q2Q%173.23%
Revenue 1Y (TTM)-4.73%
Revenue growth 3Y-3.57%
Revenue growth 5Y3.76%
Sales Q2Q%-0.4%

3.2 Future

  • SBS is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.95% yearly.
  • Based on estimates for the next years, SBS will show a small growth in Revenue. The Revenue will grow by 5.12% on average per year.
EPS Next Y-11.28%
EPS Next 2Y9.74%
EPS Next 3Y13.19%
EPS Next 5Y11.95%
Revenue Next Year0.4%
Revenue Next 2Y3.61%
Revenue Next 3Y4.89%
Revenue Next 5Y5.12%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
SBS.DE Yearly Revenue VS EstimatesSBS.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 100M 200M 300M
SBS.DE Yearly EPS VS EstimatesSBS.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1 2 3 4

5

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 15.14 indicates a correct valuation of SBS.
  • Compared to the rest of the industry, the Price/Earnings ratio of SBS indicates a rather cheap valuation: SBS is cheaper than 93.85% of the companies listed in the same industry.
  • When comparing the Price/Earnings ratio of SBS to the average of the S&P500 Index (26.99), we can say SBS is valued slightly cheaper.
  • Based on the Price/Forward Earnings ratio of 10.49, the valuation of SBS can be described as reasonable.
  • 87.69% of the companies in the same industry are more expensive than SBS, based on the Price/Forward Earnings ratio.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 28.02, SBS is valued rather cheaply.
Industry RankSector Rank
PE 15.14
Fwd PE 10.49
SBS.DE Price Earnings VS Forward Price EarningsSBS.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, SBS is valued cheaply inside the industry as 89.23% of the companies are valued more expensively.
  • 60.00% of the companies in the same industry are cheaper than SBS, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 75.83
EV/EBITDA 7.55
SBS.DE Per share dataSBS.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

  • SBS's earnings are expected to grow with 13.19% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)6.9
EPS Next 2Y9.74%
EPS Next 3Y13.19%

5

5. Dividend

5.1 Amount

  • SBS has a Yearly Dividend Yield of 2.99%. Purely for dividend investing, there may be better candidates out there.
  • Compared to an average industry Dividend Yield of 1.14, SBS pays a better dividend. On top of this SBS pays more dividend than 93.85% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.81, SBS pays a better dividend.
Industry RankSector Rank
Dividend Yield 2.99%

5.2 History

  • The dividend of SBS decreases each year by -7.63%.
Dividend Growth(5Y)-7.63%
Div Incr Years0
Div Non Decr Years5
SBS.DE Yearly Dividends per shareSBS.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

  • 45.53% of the earnings are spent on dividend by SBS. This is a bit on the high side, but may be sustainable.
DP45.53%
EPS Next 2Y9.74%
EPS Next 3Y13.19%
SBS.DE Yearly Income VS Free CF VS DividendSBS.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M 40M
SBS.DE Dividend Payout.SBS.DE Dividend Payout, showing the Payout Ratio.SBS.DE Dividend Payout.PayoutRetained Earnings

STRATEC SE

FRA:SBS (2/23/2026, 11:57:03 AM)

19.98

-0.42 (-2.06%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-07
Earnings (Next)N/A
Inst Owners37.43%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap242.96M
Revenue(TTM)257.62M
Net Income(TTM)16.02M
Analysts80
Price Target34.95 (74.92%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.99%
Yearly Dividend0.55
Dividend Growth(5Y)-7.63%
DP45.53%
Div Incr Years0
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.36%
PT rev (3m)1.07%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-3.3%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1%
Revenue NY rev (3m)-1.75%
Valuation
Industry RankSector Rank
PE 15.14
Fwd PE 10.49
P/S 0.94
P/FCF 75.83
P/OCF 11.12
P/B 1.01
P/tB 1.93
EV/EBITDA 7.55
EPS(TTM)1.32
EY6.61%
EPS(NY)1.91
Fwd EY9.54%
FCF(TTM)0.26
FCFY1.32%
OCF(TTM)1.8
OCFY8.99%
SpS21.19
BVpS19.74
TBVpS10.36
PEG (NY)N/A
PEG (5Y)6.9
Graham Number24.22
Profitability
Industry RankSector Rank
ROA 3.72%
ROE 6.67%
ROCE 7.38%
ROIC 5.32%
ROICexc 5.68%
ROICexgc 8.34%
OM 10.94%
PM (TTM) 6.22%
GM 29.65%
FCFM 1.24%
ROA(3y)4.79%
ROA(5y)6.56%
ROE(3y)8.69%
ROE(5y)12.02%
ROIC(3y)6.93%
ROIC(5y)8.13%
ROICexc(3y)7.69%
ROICexc(5y)10.12%
ROICexgc(3y)11.48%
ROICexgc(5y)16.01%
ROCE(3y)9.61%
ROCE(5y)11.28%
ROICexgc growth 3Y-26.1%
ROICexgc growth 5Y2.82%
ROICexc growth 3Y-25.31%
ROICexc growth 5Y3.93%
OM growth 3Y-14.59%
OM growth 5Y5.17%
PM growth 3Y-23.53%
PM growth 5Y-1.6%
GM growth 3Y-0.97%
GM growth 5Y4.52%
F-Score7
Asset Turnover0.6
Health
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF 41.27
Debt/EBITDA 2.49
Cap/Depr 99.05%
Cap/Sales 7.24%
Interest Coverage 5.44
Cash Conversion 46.48%
Profit Quality 20%
Current Ratio 4.19
Quick Ratio 1.65
Altman-Z 2.66
F-Score7
WACC6.65%
ROIC/WACC0.8
Cap/Depr(3y)101.4%
Cap/Depr(5y)105.66%
Cap/Sales(3y)6.8%
Cap/Sales(5y)7.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)4.26%
EPS 3Y-26.21%
EPS 5Y2.2%
EPS Q2Q%173.23%
EPS Next Y-11.28%
EPS Next 2Y9.74%
EPS Next 3Y13.19%
EPS Next 5Y11.95%
Revenue 1Y (TTM)-4.73%
Revenue growth 3Y-3.57%
Revenue growth 5Y3.76%
Sales Q2Q%-0.4%
Revenue Next Year0.4%
Revenue Next 2Y3.61%
Revenue Next 3Y4.89%
Revenue Next 5Y5.12%
EBIT growth 1Y-3.3%
EBIT growth 3Y-17.64%
EBIT growth 5Y9.13%
EBIT Next Year47.63%
EBIT Next 3Y26.73%
EBIT Next 5Y17.92%
FCF growth 1Y114.46%
FCF growth 3Y-10.96%
FCF growth 5YN/A
OCF growth 1Y1784.43%
OCF growth 3Y-8.44%
OCF growth 5Y18.03%

STRATEC SE / SBS.DE FAQ

Can you provide the ChartMill fundamental rating for STRATEC SE?

ChartMill assigns a fundamental rating of 5 / 10 to SBS.DE.


What is the valuation status for SBS stock?

ChartMill assigns a valuation rating of 5 / 10 to STRATEC SE (SBS.DE). This can be considered as Fairly Valued.


How profitable is STRATEC SE (SBS.DE) stock?

STRATEC SE (SBS.DE) has a profitability rating of 4 / 10.


Can you provide the financial health for SBS stock?

The financial health rating of STRATEC SE (SBS.DE) is 5 / 10.


Can you provide the expected EPS growth for SBS stock?

The Earnings per Share (EPS) of STRATEC SE (SBS.DE) is expected to decline by -11.28% in the next year.